PIK3CA Mutations Are Common in Lobular Carcinoma in Situ, but Are Not a Biomarker of Progression
Breast Cancer Research - United Kingdom
doi 10.1186/s13058-016-0789-y
Full Text
Open PDFAbstract
Available in full text
Date
January 17, 2017
Authors
Publisher
Springer Science and Business Media LLC